TMDX Q3 2021 Earnings — TransMedics Group, Inc. Revenue & Financial Results | Market Cap Arena

TMDXTransMedics Group, Inc.

$4B

Q3 2021 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$5M-24.3% YoY

Gross Profit

$4M70.3% margin

Operating Income

-$12M-218.3% margin

Net Income

-$13M-241.4% margin

EPS (Diluted)

$-0.47

QoQ Revenue Growth

-34.3%

Cash Flow

Operating Cash Flow

-$9M

Free Cash Flow

-$9M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$131M

Total Liabilities

$53M

Stockholders' Equity

$79M

Cash & Equivalents

$22M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5M	$7M	-24.3%
Gross Profit	$4M	$5M	-25.1%
Operating Income	-$12M	-$5M	-154.3%
Net Income	-$13M	-$5M	-154.8%

Revenue Segments

Ocs Heart Product

$3M53%

Ocs Lung Product

$3M47%

Geographic Segments

U S

$3M62%

Non Us And Uk

$2M38%